ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 93 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 3.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 469 | 0.0% | 0.00% | – |
Q2 2023 | $0 | -100.0% | 469 | 0.0% | 0.00% | – |
Q1 2023 | $1 | 0.0% | 469 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 469 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | -96.9% | 469 | -97.5% | 0.00% | – |
Q2 2022 | $32,000 | -56.2% | 18,878 | -46.8% | 0.00% | – |
Q1 2022 | $73,000 | -20.7% | 35,516 | +44.9% | 0.00% | -100.0% |
Q4 2021 | $92,000 | +15.0% | 24,515 | +59.4% | 0.00% | 0.0% |
Q3 2021 | $80,000 | +7900.0% | 15,382 | +5908.6% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 256 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 256 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 256 | -20.7% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 323 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | -50.0% | 323 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -50.0% | 323 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | 0.0% | 323 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | – | 323 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 15,832,611 | $68,080,000 | 3.54% |
Matrix Capital Management Company, LP | 28,000,000 | $120,400,000 | 3.21% |
Virtus ETF Advisers LLC | 50,655 | $218,000 | 0.46% |
TFG Asset Management GP Ltd | 500,000 | $2,150,000 | 0.27% |
Rock Springs Capital Management LP | 800,000 | $3,440,000 | 0.13% |
Orbimed Advisors | 1,350,655 | $5,808,000 | 0.09% |
Vident Investment Advisory, LLC | 289,340 | $1,244,000 | 0.07% |
WS MANAGEMENT LLLP | 185,537 | $798,000 | 0.05% |
Rathbones Group PLC | 285,722 | $1,229,000 | 0.04% |
Tekla Capital Management LLC | 228,496 | $983,000 | 0.04% |